JPWO2022215619A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022215619A5
JPWO2022215619A5 JP2023512977A JP2023512977A JPWO2022215619A5 JP WO2022215619 A5 JPWO2022215619 A5 JP WO2022215619A5 JP 2023512977 A JP2023512977 A JP 2023512977A JP 2023512977 A JP2023512977 A JP 2023512977A JP WO2022215619 A5 JPWO2022215619 A5 JP WO2022215619A5
Authority
JP
Japan
Prior art keywords
component
composition
secretion
suppression
nootkatone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023512977A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022215619A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/015872 external-priority patent/WO2022215619A1/ja
Publication of JPWO2022215619A1 publication Critical patent/JPWO2022215619A1/ja
Publication of JPWO2022215619A5 publication Critical patent/JPWO2022215619A5/ja
Pending legal-status Critical Current

Links

JP2023512977A 2021-04-07 2022-03-30 Pending JPWO2022215619A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021065419 2021-04-07
PCT/JP2022/015872 WO2022215619A1 (ja) 2021-04-07 2022-03-30 Glp-1分泌促進用組成物

Publications (2)

Publication Number Publication Date
JPWO2022215619A1 JPWO2022215619A1 (https=) 2022-10-13
JPWO2022215619A5 true JPWO2022215619A5 (https=) 2025-04-03

Family

ID=83545518

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512977A Pending JPWO2022215619A1 (https=) 2021-04-07 2022-03-30

Country Status (5)

Country Link
US (1) US20240139226A1 (https=)
EP (1) EP4309515A4 (https=)
JP (1) JPWO2022215619A1 (https=)
TW (1) TW202304312A (https=)
WO (1) WO2022215619A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024090424A1 (ja) * 2022-10-28 2024-05-02 株式会社林原 口当たり改善用組成物、飲食品組成物及びその製造方法、並びに口当たりを改善する方法
WO2024123824A1 (en) * 2022-12-05 2024-06-13 Enveda Therapeutics, Inc. Nootkatone for the treatment of pruritus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56147139A (en) 1980-04-18 1981-11-14 Kyocera Corp Input and output control device
US5494667A (en) * 1992-06-04 1996-02-27 Kabushiki Kaisha Hayahibara Topically applied hair restorer containing pine extract
JPH1096A (ja) 1996-06-13 1998-01-06 Nikken Chem Co Ltd 微生物を用いるエリスリトールの製造方法
JP3967563B2 (ja) 2000-05-29 2007-08-29 株式会社林原生物化学研究所 3”−α−モノグルコシルナリンジン含有組成物、その製造方法およびその利用方法
JP4745764B2 (ja) * 2004-09-09 2011-08-10 花王株式会社 Ampk活性化剤
JP5042519B2 (ja) 2006-04-18 2012-10-03 東洋精糖株式会社 ナリンジン組成物、その製造方法及び用途
CN101829243A (zh) * 2010-05-22 2010-09-15 祝根华 一种牛皮癣及青春痘外用速效膏及生产工艺
WO2012168474A1 (en) * 2011-06-10 2012-12-13 Monell Chemical Senses Center Novel methods
CN107114753A (zh) * 2011-12-06 2017-09-01 日本水产株式会社 食盐替代物、包含其的食品或饮料及应用
JP5818259B2 (ja) * 2012-02-27 2015-11-18 国立大学法人 東京大学 Tgr5作動剤
WO2014090569A1 (en) * 2012-12-13 2014-06-19 Unilever N.V. Edible composition comprising an extract of inula racemosa and naringin
JP6441052B2 (ja) * 2014-12-05 2018-12-19 東洋精糖株式会社 フラボノイド配糖体エステル、該フラボノイド配糖体エステルを含む抗菌剤、抗酸化剤および抗炎症剤
JP2016138070A (ja) 2015-01-28 2016-08-04 長瀬産業株式会社 Glp−1分泌促進剤
WO2017159725A1 (ja) 2016-03-16 2017-09-21 サントリーホールディングス株式会社 Glp-1分泌促進用組成物及びその製造方法
JP6839494B2 (ja) * 2016-03-25 2021-03-10 東洋精糖株式会社 αモノグルコシルロイフォリン、αモノグルコシルロイフォリンの製造方法、αモノグルコシルロイフォリンを含むリパーゼ阻害剤、および抗糖化剤
CN106333956A (zh) * 2016-08-29 2017-01-18 杨延芳 一种药物组合物及其在治疗急性脊髓炎的应用
US20190247449A1 (en) * 2016-09-14 2019-08-15 Grace Breeding Ltd. Compositions comprising a non-pathogenic bacteria and methods for protecting plant and animal hosts from fungal, bacterial and viral diseases
US20180344685A1 (en) * 2017-06-02 2018-12-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for increased glucose uptake and fat metabolism
US20210236577A1 (en) * 2018-08-23 2021-08-05 Delacon Biotechnik Gmbh Livestock feed additive
US11197880B2 (en) * 2019-03-27 2021-12-14 Ingredients By Nature, Llc Use of eriocitrin compositions for increasing GLP-1 levels
EP3986386A2 (en) * 2019-06-20 2022-04-27 Société des Produits Nestlé S.A. Compositions and methods using thymol and/or carvacrol for induction of autophagy
JP7623289B2 (ja) * 2019-10-30 2025-01-28 東洋精糖株式会社 セルライト改善用皮膚外用剤、およびセルライト改善方法
JP7481876B2 (ja) * 2020-03-27 2024-05-13 株式会社コーセー コラーゲンに関連した処置のための剤

Similar Documents

Publication Publication Date Title
JPWO2022215619A5 (https=)
Rubio-Almanza et al. Obesity and type 2 diabetes: also linked in therapeutic options
EP2636680A3 (en) Composition and methods for treatment of congestive heart failure
WO2003032968A1 (fr) Compositions destinees a reduire le stress oxydatif
JP6438944B2 (ja) インスリングラルギン/リキシセナチド固定比率製剤
WO2005039546A3 (en) Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
JP2005213227A (ja) D−プシコースの血糖上昇抑制効果の利用
JP2008500955A (ja) 糖尿病の治療に使用するための方法及び組成物
JP2017519046A (ja) 甘味受容体アンタゴニスト組成物
Ahn et al. Premeal consumption of a protein-enriched, dietary fiber-fortified bar decreases total energy intake in healthy individuals
CN104394864B (zh) 含有芝麻素类、γ-谷维素和米胚芽油的组合物
JPH10265397A (ja) 肥満予防剤
WO2013067485A1 (en) Nutritional supplement for weight management
MX337606B (es) Metodo y composiciones farmaceuticas para el tratamiento de la hiperglicemia postprandial de la diabetes tipo ii, a traves de la mucosa bucal.
WO2006126673A1 (ja) 組み合わせによる糖尿病治療薬
WO2005030195A1 (en) (-)-hydroxycitric acid for delaying gastric emptying
JP2004000171A (ja) マカを含有した機能性食品
JP5394644B2 (ja) アスペルロシドまたはその類縁体を含む筋肉増強剤
WO2023074709A1 (ja) リラックス感向上剤、同リラックス感向上剤を含む機能性食品及び医薬部外品
JP4723320B2 (ja) 血中レプチン濃度上昇剤
KR102884917B1 (ko) 항비만제의 근감소 부작용을 개선 또는 억제하기 위한 라세탐 계열 화합물, 및 라세탐 계열 화합물과 항비만제를 유효성분으로 포함하는 비만 예방 또는 치료용 약학적 조성물
Yingyi et al. Advances in preoperative medical management of metabolic surgery
CN1309559A (zh) 合成制备的治疗和/或预防超重的组合物及其用途
WO2006106888A1 (ja) パチュリー油及び食物繊維を含有する排便促進用経口組成物
Yagiz et al. Novel Co-agonists of GLP-1 and GIP Receptors Produce Robust Weight Loss in a Rodent Model of Obesity